Eun-Ok Lee

Prof. Eun-Ok Lee


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2012 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
HKHyun Suk Ko
Hyun Suk Ko
HLHyo-Jeong Lee
Hyo-Jeong Lee
Sung-Hoon KimSung-Hoon Kim
Sung-Hoon Kim
ELEun-Ok Lee
Eun-Ok Lee

1 January 2018 in Life Sciences
Verified
Journal Article
Closed access
EIEunji Im
Eunji Im
CYChanghwan Yeo
Changhwan Yeo
HLHyo-Jeong Lee
Hyo-Jeong Lee
ELEun-Ok Lee
Eun-Ok Lee

1 September 2018 in Life Sciences
Verified
Journal Article
Closed access
EIEunji Im
Eunji Im
CYChanghwan Yeo
Changhwan Yeo
ELEun-Ok Lee
Eun-Ok Lee

17 December 2015 in Journal of Natural Products
Verified
Journal Article
Closed access
CKChi Gu Kang
Chi Gu Kang
HLHyo-Jeong Lee
Hyo-Jeong Lee
Sung-Hoon KimSung-Hoon Kim
Sung-Hoon Kim
ELEun-Ok Lee
Eun-Ok Lee

14 May 2014 in Journal of Natural Products
Verified
Journal Article
Closed access
JKJi Sung Kim
Ji Sung Kim
CKChi Gu Kang
Chi Gu Kang
Sung-Hoon KimSung-Hoon Kim
Sung-Hoon Kim
ELEun-Ok Lee
Eun-Ok Lee

30 July 2014 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SCSun-Mi Cho
Sun-Mi Cho
ELEun-Ok Lee
Eun-Ok Lee
Sung-Hoon KimSung-Hoon Kim
Sung-Hoon Kim
HLHyo-Jeong Lee
Hyo-Jeong Lee
The essential oil of Pinus koraiensis (EOPK) is biologically active compound obtained from the leaves of P. koraiensis. The goal of this study was to investigate the anti-cancer mechanism of EOPK in HCT116 colorectal cancer cells. HCT116 cell proliferation was assessed by conducting crystal violet and BrdU assays. To assess the effects of EOPK on cell migration, we performed a wound-healing assay. Further, the contribution of PAK1 to EOPK-induced AKT and extracellular signal-regulated kinase (ERK) suppression was assessed by siRNA-mediated PAK1 knockdown. Changes to the expression and phosphorylation of PAK1 and its effectors were determined by western blotting, and changes to the actin cytoskeleton were determined by performing an immunofluorescence assay. EOPK significantly decreased HCT116 cell proliferation and migration, and induced G1 arrest without affecting normal cells. Additionally, EOPK suppressed the expression of PAK1, and decreased ERK and AKT phosphorylation in HCT116 cells. Finally, EOPK suppressed β-catenin, cyclin D1, and CDK4/6 expression. Our studies indicate that EOPK significantly reduced proliferation and migration of colorectal cancer cells. Furthermore, EOPK suppressed PAK1 expression in a dose-dependent manner, and this suppression of PAK1 led to inhibition of ERK, AKT, and β-catenin activities. Our findings suggest that EOPK exerts its anticancer activity via the inhibition of PAK1 expression, suggesting it may be a potent chemotherapeutic agent for colorectal cancer.